Welcome to the Porton Newsroom
2025 Duchenne Awareness Day
Join the WeCare Program in celebrating World Duchenne Awareness Day. Support DMD families and promote understanding of Duchenne Muscular Dystrophy.
Porton Newsletter - August 2025 Recap
Technical Enabling
Services & Solutions
Company Events
ESG
Marketing Activities
Porton to Showcase Integrated CDMO Expertise at BIOSPAIN 2025
Porton to Showcase Integrated CDMO Expertise at BIOSPAIN 2025
Porton's End-to-End CMC Development Accelerates Market Approval for Innovative ALK Inhibitor Dirozalkib (Xuanfeining) Tablets
As the sole CDMO service provider for the active pharmaceutical ingredient (API) of Dirozalkib
Porton Supports BioNova's BN104 Program in Achieving Milestone Entry into Overseas Markets
BioNova & Porton Annual Collaboration Review and Award Ceremony
Porton 2025 H1 Performance Highlights
PORTON 2025 H1 PERFORMANCE HIGHLIGHTS
Porton Nominated for the 2025 Sedex Supply Chain Award
Porton Pharma Solutions Ltd. (“Porton”) was honored with a nomination for the Positive Endeavors Award at the 2025 Sedex Supply Chain Award Ceremony. The recognition highlights Porton’s unwavering commitment to sustainability and responsible business practices.
Porton to Showcase Integrated CDMO Expertise at CPHI Frankfurt 2025
The 2025 CPhI Frankfurt event will take place from October 28–30 at Messe Frankfurt, Germany, gathering over 62,000 attendees and 2,400 exhibitors from more than 166 countries.
Porton Newsletter - July 2025 Recap
Technical Enabling
Services & Solutions
Company Events
Marketing Activities
